Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

David Parrot

CFO at Scribe Therapeutics, Inc. (SCTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$16K
Total bought / sold$40K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jul 27SEC SCTXScribe Therapeutics, Inc. Buy 1,333new position $15.00 $20K +41.1%
Jul 27SEC SCTXScribe Therapeutics, Inc. Buy 1,333new position $15.00 $20K +41.1%
  • Buy

    CFO David Parrot bought $20K of SCTX at $15.00 — first open-market purchase in our records; opens a new position.

  • Buy

    CFO David Parrot bought $20K of SCTX at $15.00 — opens a new position.